Listed times are in Central European Time (CET)

WELCOME TO DAY ONE

Session 1

Chair: Omer Dushek

Benny Chain The UCL Institute of Immunity and Transplantation, UK

'Private and shared T cell receptor clusters in cancer immunity'

Q&A: 13:25-13:35

Thierry Mora École Normale Supérieure (ENS) Paris, France

'How to maintain a diverse T-cell response'

Q&A: 13:55-14:05

Proffered Paper 1

Q&A: 14:15-14:20

Proffered Paper 2

Q&A: 14:25-14:35

REFRESHMENT BREAK

Session 2

Chair: Melita Irving

FLASH TALKS 1

Armita Nourmohammad Yale School of Medicine, USA

'Design principles of the adaptive immune response in T-cells'

Q&A: 15:35-15:45

INDUSTRY SPOTLIGHT - ImmuneWatch

Proffered Paper 3

Q&A: 16:10-16:15

Proffered Paper 4

Q&A: 16:25-16:30

Marta Luksza MSKCC, USA

'Predicting tumor evolution to design vaccines'

Q&A: 16:50-17:00

SUMMARY AND CLOSE

Listed times are in Central European Time (CET)

WELCOME TO DAY TWO

Session 3

Chair: Benny Chain

Omer Dushek University of Oxford, UK

'Generation of super-selective T cells by engineering buffered signalling'

Q&A: 13:25-13:35

Dirk Busch Technical University of Munich, Germany

Q&A: 13:55-14:05

Proffered Paper 5

Q&A: 14:15-14:20

REFRESHMENT BREAK

Session 4

Chair: Armita Nourmohammad

FLASH TALKS 2

Melita Irving University of Lausanne, Switzerland

'Engineering specificity, safety and function into T cells against cancer'

Q&A: 15:20-15:30

Proffered Paper 6

Q&A: 15:40-15:45

Chris Garcia Stanford University, USA

'Inconvenient structural truths for decoding and engineering T cell recognition'

Q&A: 16:05-16:15

OPEN FORUM

An informal discussion session where speakers and participants are invited to discuss the key talking points from the day

SUMMARY AND CLOSE